Phase 11 study of high-dose dexamethasone-based association in acute and delayed high-dose cisplatin-induced emesis - JCOG study 9413
1997

High-Dose Dexamethasone for Nausea and Vomiting in Lung Cancer Patients

Sample size: 33 publication Evidence: moderate

Author Information

Author(s): I Sekine, Y Nishiwaki, R Kakinuma, K Kubota, F Hojo, T Matsumoto, H Ohmatsu, M Yokozaki, K Goto, T Miyamoto, J Takafuji, T Kodama

Primary Institution: National Cancer Center Hospital East

Hypothesis

Can high-dose dexamethasone effectively control acute and delayed nausea and vomiting in lung cancer patients receiving cisplatin?

Conclusion

High-dose dexamethasone combined with metoclopramide resulted in total control of nausea and vomiting in about half of the patients treated with cisplatin.

Supporting Evidence

  • 85% of patients had no nausea or vomiting on day 1.
  • 48% of patients achieved total control of nausea and vomiting over five days.
  • Patients were aged between 15 and 74 years.
  • High-dose dexamethasone was administered over five days.

Takeaway

This study tested a strong medicine to help cancer patients not feel sick after treatment, and it worked for many of them.

Methodology

Patients with lung cancer receiving cisplatin were treated with high-dose dexamethasone and other antiemetics, and their responses were recorded over five days.

Limitations

The study had a small sample size and did not include patients with certain health conditions.

Participant Demographics

The study included 33 patients, 12 (36%) were female, and 18 (55%) were under 60 years old.

Statistical Information

Confidence Interval

95% CI: 32.5-64.8%

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication